Shares of Bayer Aktiengesellschaft (ETR:BAYN – Get Free Report) were down 0.8% on Tuesday . The stock traded as low as €26.04 ($28.00) and last traded at €26.17 ($28.14). Approximately 2,690,000 shares changed hands during trading, The stock had previously closed at €26.38 ($28.37).
Bayer Aktiengesellschaft Stock Up 1.5 %
The stock’s fifty day simple moving average is €27.59 and its two-hundred day simple moving average is €28.88. The company has a debt-to-equity ratio of 129.38, a current ratio of 1.31 and a quick ratio of 0.72. The company has a market capitalization of $25.77 billion, a price-to-earnings ratio of -8.27, a PEG ratio of 36.39 and a beta of 0.97.
Bayer Aktiengesellschaft Company Profile
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.
Further Reading
- Five stocks we like better than Bayer Aktiengesellschaft
- Breakout Stocks: What They Are and How to Identify Them
- Celebrate July 4th with These Red, White, & Blue Chip Stocks
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- AbbVie Stock: A Perfect Dip for Investors to Buy
- 3 REITs to Buy and Hold for the Long Term
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
Receive News & Ratings for Bayer Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.
